KALA BIO, Inc. (KALA)
(Delayed Data from NSDQ)
$6.51 USD
+0.01 (0.18%)
Updated May 24, 2024 03:28 PM ET
After-Market: $6.50 -0.01 (-0.18%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for KALA BIO, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -42.20 | -44.82 | -142.61 | -104.33 | -94.35 |
Depreciation/Amortization & Depletion | 1.56 | 1.96 | 2.52 | 1.97 | 1.80 |
Net Change from Assets/Liabilities | 8.90 | 0.49 | -10.62 | -3.57 | -11.94 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.82 | -36.54 | 42.47 | 15.24 | 11.76 |
Net Cash From Operating Activities | -27.93 | -78.91 | -108.24 | -90.69 | -92.72 |
Property & Equipment | -0.56 | -0.20 | -0.79 | -1.94 | -1.34 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 62.91 | -4.65 | 0.00 | 0.00 |
Investments | 0.13 | 0.01 | 76.25 | -76.27 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -4.65 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.43 | 62.72 | 70.80 | -78.21 | -1.34 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 20.55 | 32.10 | 42.82 | 160.66 | 9.01 |
Issuance (Repayment) of Debt | -10.00 | -40.04 | -0.26 | -0.03 | -0.03 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.04 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 8.51 | -7.94 | 42.55 | 160.63 | 8.98 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -19.85 | -24.13 | 5.12 | -8.28 | -85.07 |
Cash at Beginning of Period | 70.75 | 94.88 | 89.76 | 98.03 | 183.10 |
Cash at End of Period | 50.90 | 70.75 | 94.88 | 89.76 | 98.03 |
Diluted Net EPS | -17.35 | -29.48 | -109.50 | -99.50 | -138.00 |
Fiscal Year End for KALA BIO, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -11.81 | -42.20 | -33.57 | -24.87 | -14.46 |
Depreciation/Amortization & Depletion | 0.38 | 1.56 | 1.17 | 0.79 | 0.41 |
Net Change from Assets/Liabilities | -2.05 | 8.90 | 11.07 | 2.17 | 1.41 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.63 | 3.82 | 1.09 | 4.63 | 2.95 |
Net Cash From Operating Activities | -10.84 | -27.93 | -20.23 | -17.28 | -9.68 |
Property & Equipment | -0.01 | -0.56 | -0.56 | -0.28 | -0.11 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.13 | 0.13 | -9.87 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | -0.43 | -0.42 | -10.14 | -0.11 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 8.56 | 20.55 | 18.01 | 17.97 | 14.90 |
Issuance (Repayment) of Debt | 0.00 | -10.00 | -10.00 | -10.00 | -10.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.12 | -2.04 | -2.04 | -2.04 | -2.04 |
Net Cash from Financing Activities | 8.44 | 8.51 | 5.97 | 5.93 | 2.86 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -2.42 | -19.85 | -14.68 | -21.49 | -6.93 |
Cash at Beginning of Period | 50.90 | 70.75 | 70.75 | 70.75 | 70.75 |
Cash at End of Period | 48.48 | 50.90 | 56.06 | 49.26 | 63.81 |
Diluted Net EPS | -4.20 | -2.59 | -3.41 | -4.36 | -6.99 |